Moderna Sends Coronavirus Vaccine Candidate To NIAID For First Human Trial Of Such A Vaccine
February 25, 2020
The Wall Street Journal (2/24, Loftus, Subscription Publication) reports Moderna shipped its first batch of a coronavirus vaccine candidate to the NIAID, which is expected to launch the first human trial of such a vaccine in April.